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Catecholamines play an important role in controlling
white adipose tissue function and development. b- and
a2-adrenergic receptors (ARs) couple positively and
negatively, respectively, to adenylyl cyclase and are co-
expressed in human adipocytes. Previous studies have
demonstrated increased adipocyte a2/b-AR balance in
obesity, and it has been proposed that increased a2-ARs
in adipose tissue with or without decreased b-ARs may
contribute mechanistically to the development of in-
creased fat mass. To critically test this hypothesis, adi-
pocyte a2/b-AR balance was genetically manipulated in
mice. Human a2A-ARs were transgenically expressed in
the adipose tissue of mice that were either homozygous
(2/2) or heterozygous (1/2) for a disrupted b3-AR allele.
Mice expressing a2-ARs in fat, in the absence of b3-ARs
(b3-AR 2/2 background), developed high fat diet-in-
duced obesity. Strikingly, this effect was due entirely to
adipocyte hyperplasia and required the presence of a2-
ARs, the absence of b3-ARs, and a high fat diet. Of note,
obese a2-transgenic, b3 2/2 mice failed to develop insu-
lin resistance, which may reflect the fact that expanded
fat mass was due to adipocyte hyperplasia and not adi-
pocyte hypertrophy. In summary, we have demon-
strated that increased a2/b-AR balance in adipocytes
promotes obesity by stimulating adipocyte hyperplasia.
This study also demonstrates one way in which two
genes (a2 and b3-AR) and diet interact to influence fat
mass.
The contribution of catecholamines to the control of meta-
bolic events occurring in mature adipocytes such as lipolysis
has been well documented. Human adipocytes express signifi-
cant levels of b1-, b2-, and a2-adrenergic receptors (ARs),1
which couple positively (b1 and b2) and negatively (a2) to
adenylyl cyclase (1). Endogenous ligands, epinephrine and
norepinephrine, activate both classes of receptors (1, 2), sug-
gesting an important role for a2/b-AR balance in regulating
lipolysis and energy balance (1, 3, 4). Adipocytes from obese
humans have increased a2-ARs, a2/b-AR ratios, and a2-AR-
mediated responses (3–9). In addition, longitudinal studies in
animal models have shown that a2-ARs are increased with fat
cell hypertrophy and that increased a2/b-AR balance is corre-
lated with obesity (5, 10, 11). Thus, it has been proposed that
a2/b-AR balance affects adipose tissue development.
Murine adipocytes differ from human adipocytes in that they
express many b3-ARs, in addition to b1- and b2-ARs, and very
few a2-ARs (1, 12). b3-ARs, like b1- and b2-ARs, couple posi-
tively to adenylate cyclase. In mice, b3-ARs are expressed
predominantly in white and brown adipocytes, where they are
thought to play an important role in regulating lipolysis and
thermogenesis (1). Surprisingly, b3-AR gene knockout mice
have little or no increase in body weight and only a slight
increase in body fat (13, 14). The absence of greater effects of
b3-AR deficiency on fat stores could be due to the fact that
murine adipocytes, unlike human adipocytes, express very few
a2-ARs (12), which if present would antagonize actions medi-
ated by residual b1- and b2-ARs and even initiate some addi-
tional effects.
To assess the importance of a2/b-AR balance in adipocytes in
vivo, we have combined gene targeting and transgenic ap-
proaches to create mice with increased a2/b-AR balance in
adipose tissue. Specifically, the aP2 promoter (15) was used to
drive adipocyte-specific expression of a2-ARs in mice that were
either homozygous (2/2) or heterozygous (1/2) for a disrupted
b3-AR allele. Mice with genetically altered a2/b-AR balance
were then assessed for sensitivity to high fat diet-induced obe-
sity. Of note, mice with increased a2/b-AR balance developed
diet-induced obesity secondary to adipocyte hyperplasia. These
results strongly suggest that a2/b-AR balance plays an impor-
tant role in regulating fat mass.
MATERIALS AND METHODS
Transgenic Mice—All genetically modified animals were created and
maintained on an FVB/n inbred background and were genetically iden-
tical except for the specified genetic alterations. Creation of b3 2/2
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mice, homozygous for the Ardb3tm1Lowl allele, has previously been de-
scribed (13). The aP2-a2A-AR transgene (see Fig. 1a) was constructed
by fusing mouse aP2 fatty acid-binding protein 59-flanking regulatory
sequence (16), 25.4 kb (EcoRI) to 121 base pairs (PstI), to 1.4 kb (NcoI
to HindIII) of human genomic DNA containing the human a2C10 gene
(16) and the splice/polyadenylation site of SV40. Comparisons between
mice with Tg(ADRA2A)Lowl and without the a2-AR transgene were all
performed on littermates. Animals were group-housed at 24 °C, had
free access to food and water, and were handled in accordance with the
principles and guidelines established by the National Institutes of
Health. Where indicated, mice were weaned at the age of 3 weeks onto
low fat (#D12450) or high fat (#D12451) diets (Research Diets, New
Brunswick, NJ). Diets were matched for protein content and had the
following composition (as a % of total calories): low fat diet (10% fat,
70% carbohydrate, and 20% protein); high fat diet (45% fat, 35% car-
bohydrate, and 20% protein).
Radioligand Binding Assays—Specific binding of the a2-adrenergic
receptor antagonist (3H)RX-821002 to fat cell membranes was deter-
mined after 30 min of incubation at 25 °C without (total binding) or
with (nonspecific binding) 10 mM epinephrine (12). The maximal num-
ber of a2-AR binding sites (Bmax) and equilibrium dissociation constants
(KD) were calculated using Scatchard analysis of saturation binding
data.
Lipolysis—The in vitro lipolytic response of isolated white fat cells to
epinephrine without or with 10 mM selective a2-adrenergic receptor
antagonist RX-821002 was measured. Adipocytes were isolated, and
lipolysis was measured as described previously (12). The in vivo lipo-
lytic response of conscious overnight-fasted mice was measured 10 min
after a 0.1 mg/kg epinephrine intraperitoneal injection by non-esterified
fatty acid blood levels.
mRNA Analyses—Total RNA was isolated using a Brinkman homog-
enizer and RNA STAT-60 solution (Tel-Test “B,” Inc., Friendswood,
TX). a2-AR transgene mRNA was analyzed by Northern blotting using
either a specific 1.5-kb SV40 probe or 1.2-kb a2C10 probe. UCP1 mRNA
levels were analyzed by Northern blotting using a specific mouse 0.3-kb
UCP1 cDNA probe.
Oxygen Consumption—Oxygen consumption was measured in
102week-old mice using the OXYMAX system 4.93 (Colombus Instru-
ments, Colombus, OH), with a settling time of 100 s, a measuring time
of 50 s, and with the reference as room air. The animals were placed in
four 0.3-liter chambers at thermal neutrality (30 °C).
Assessment of Fat Stores—The measurement of total body lipid con-
tent was performed as described previously (17, 18). Fat cell size and fat
cell number per fat depot were determined in perigonadal fat samples
using the Hirsch and Gallian method (19) of lipid extraction, osmium
tetroxide fixation, and Coulter Counter analysis. Histological determi-
nations were performed as described previously (microscopic assess-
ment of fat cell size; 600 cells per depot quantified in paraffin-embed-
ded, inguinal fat pad sections from female mice) (20, 21).
Circulating Blood Metabolites and Hormones—Whole blood was col-
lected and analyzed for blood glucose levels (One Touch blood glucose
meter, Lifescan Inc., Milpitas, CA). Serum was isolated and assayed for
non-esterified fatty acids (NEFA C kit, Wako Pure Chemical Industries,
Ltd.), insulin, and leptin (mouse insulin or leptin kit, Linco Research
Inc., St. Louis, MO).
RESULTS
To evaluate the physiologic significance of adipocyte a2-ARs,
we had previously generated and studied transgenic mice, on a
wild-type b3-AR (1/1) background, which express human a2A-
ARs in white and brown fat (22) (transgene shown in Fig. 1a).
Despite the presence of abundant a2-AR binding sites, trans-
genic mice had normal body weight and fat content (data not
shown). We hypothesized that the absence of an effect of a2-
ARs on fat stores was due to the presence of abundant b3-ARs,
which along with b1- and b2-ARs override the inhibitory ac-
tions of transgenically expressed a2-ARs.
In the present study, we assessed the importance of a2/b-AR
balance in adipocytes by creating a2-AR transgenic mice
(Tg(ADRA2A)1Lowl) on a b3-AR 2/2 and 1/2 background
(mice 2/2 or 1/2 for the Ardb3tm1Lowl allele) (13). The trans-
gene employed was the aP2-promoter/human a2A-AR con-
struct mentioned above (shown in Fig. 1a). As expected, mRNA
encoding human a2A-AR was expressed in white and brown
adipocytes, but not in liver, kidney, skeletal muscle, brain,
intestine, heart, or non-adipocyte cells resident within adipose
tissue (stroma-vascular fraction) (Fig. 1b). Using the a2-AR-
selective radioligand, (3H)RX-821002, few a2-AR binding sites
were found in membranes isolated from white adipocytes and
brown adipose tissue of b3 2/2 mice, confirming that murine
adipocytes express very few a2-ARs (Fig. 1c). In contrast, abun-
dant binding sites were observed in membranes isolated from
a2-trans, b3 2/2 mice (Fig. 1c). It is important to note that the
number of b1/b2-ARs (91.6 6 4.0 fmol/mg of protein; n 5 5)
observed in adipocytes of a2-trans, b3 2/2 mice was not dif-
ferent from that found in adipocytes of b3 2/2 mice (102.7 6
7.5 fmol/mg of protein; n 5 3) and was within the range of b-AR
binding sites typically observed in human fat cells (23). More-
over, the number of a2-AR binding sites detected in a2-AR
transgenic mice is comparable with that seen in human adipo-
cytes and lower than that sometimes observed in obese human
adipocytes (4, 5, 7).
Epinephrine, an agonist for both b- and a2-ARs, stimulates
lipolysis in white adipocytes by increasing cAMP levels (1). As
predicted, the human-like a2/b-AR balance obtained in a2-
trans, b3 2/2 mice shifted the epinephrine concentration-re-
sponse curve for stimulation of lipolysis to the right (Fig. 2a,
left panel). This effect was lost when the a2-AR-selective an-
tagonist, RX-821002, was present (Fig. 2a, right panel). In
FIG. 1. a, schematic representation of the aP2-a2A-AR transgene.
aP2 fatty acid-binding protein 59-flanking regulatory sequence (15),
25.4 kb (EcoRI) to 121 base pairs (PstI), was fused to 1.4 kb of human
genomic DNA containing the human a2C10 gene and the splice/poly-
adenylation site of SV40. b, fat-specific expression of a2-AR transgene
mRNA in mouse tissues and isolated fat cells. Total RNA was isolated
from tissues (left) or isolated cells from white adipose tissue (right) and
was analyzed by Northern blotting using a specific 1.5-kb SV40 probe.
c, specific binding of (3H)RX-821002 to fat cell membranes incubated for
30 min at 25 °C without (total binding) or with (nonspecific binding) 10
mM epinephrine (24). The maximal number of sites (Bmax) and equilib-
rium dissociation constant (KD) were calculated using Scatchard anal-
ysis of binding data from control (b3 2/2) and transgenic (a2-trans, b3
2/2) samples (n 5 2).
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addition, the a2-AR agonist, UK14304, inhibited lipolysis in a
concentration-dependent fashion (data not shown). Finally, dis-
placement of (3H)RX-821002 binding by epinephrine in a2-
trans, b3 2/2 fat cell membranes (data not shown) gave the
expected shallow competition curve with high and low affinity
components (KiH, 0.81 nM; KiL, 30 nM) as classically described
in human fat cells (7). These results demonstrate that a2-ARs
in transgenic adipocytes are coupled to Gi protein. As expected,
the in vivo circulating free fatty acid response to a single
injection of epinephrine was blunted in a2-trans, b3 2/2 mice
(Fig. 2b). These in vitro and in vivo studies demonstrate that
a2-ARs in white adipocytes of a2-trans, b3 2/2 mice function-
ally antagonize epinephrine-induced stimulation of lipolysis
(similar to what has been observed using isolated human white
adipocytes) (6).
The effects of a2-AR expression on brown fat function were
assessed. Cold exposure induces sympathetic nervous stimula-
tion of UCP1 gene expression and thermogenesis in brown
adipocytes, and this response plays an important role in main-
taining the body temperature of mice (25–27). Compared with
wild-type mice, b3 2/2 mice had impaired induction of UCP1
mRNA and decreased body temperature following acute cold
exposure (Fig. 2c). These responses were not inhibited further
by expression of a2-ARs in brown fat (a2-trans, b3 2/2 mice)
(Fig. 2c). In addition, a single injection of epinephrine stimu-
lated energy expenditure to a similar degree in b3 2/2 mice
and a2-trans, b3 2/2 mice (Fig. 2d). These studies suggest that
brown adipocyte function, in contrast to white adipocyte func-
tion, is not impaired by transgenic expression of a2-ARs.
To assess effects of a2/b-AR balance on body weight and total
body lipid content, b3 2/2 mice and a2-trans, b3 2/2 mice
were fed high fat and low fat diets from age 3 weeks to 20
weeks. When fed a low fat diet, body weights were similar in b3
2/2 mice and a2-trans, b3 2/2 mice (Fig. 3a). In contrast,
when fed a high fat diet, body weights were markedly greater
in a2-trans, b3 2/2 mice compared with b3 2/2 mice (Fig. 3b).
Of interest, the effect of a2-AR expression on body weight was
greater in female mice. A second line of a2-AR transgenic mice
was created which, compared with the first line, expressed 50%
lower levels of human a2-AR mRNA transcripts in white and
brown fat (data not shown). Despite this lower level of expres-
sion, high fat diet-induced obesity was also observed in the
second line of a2-AR transgenic mice on a b3-AR 2/2 back-
ground (Fig. 3c).
To assess the contribution of b3-AR deficiency in mediating
the positive effect of a2-AR expression on high fat diet-induced
obesity, a2-trans, b3 2/2 mice (line 1) were crossed with wild-
type mice (1/1 for the b3-AR allele). All offspring were 6 for
the b3-AR allele, whereas approximately 50% of offspring were
positive for the a2-AR transgene. As above, mice were fed a
high fat diet from age 3 weeks to 20 weeks. In contrast to
studies performed using b3-AR 2/2 mice, a2-AR expression
failed to promote high fat diet-induced obesity in b3-AR 1/2
mice (Fig. 3d). Thus, development of high fat diet-induced
obesity required both the presence of a2-ARs in fat and the
absence of b3-ARs.
FIG. 2. a, in vitro lipolytic response of isolated white fat cells to epinephrine without (left) or with (right) 10 mM selective a2-adrenergic receptor
antagonist RX-821002. Adipocytes were isolated, and lipolysis was measured as described previously (24). Values are the mean 6 S.E. from six
experiments. b, In vivo lipolytic response of control (b3 2/2) or transgenic (a2-trans, b3 2/2) overnight-fasted mice 10 min after a 0.1 mg/kg
epinephrine intraperitoneal injection. Basal values were 1.11 6 0.13 and 1.12 6 0.11 mM, respectively; *, p , 0.05 when compared with basal (n 5
6). c, time course of UCP1 mRNA levels (left) and body temperature (right) adaptation during a 4 °C exposure in wild type, control (b3 2/2), or
transgenic (a2-trans, b3 2/2) fed mice. UCP1 mRNA levels were analyzed by Northern blotting using a specific mouse 0.3-kb UCP1 cDNA probe
and expressed as a percent of time zero. *, p , 0.05 when compared with basal (n 5 6). d, effect of 0.1 mg/kg intraperitoneal epinephrine on O2
consumption measured 10 min after injection in control (b3 2/2) or transgenic (a2-trans, b3 2/2) fed mice. Basal values were 39.9 6 2.3 and 38.3 6
2.4 ml/kg/min, respectively; *, p , 0.05 (unpaired, 2-tailed t test) when compared with basal (n 5 6). All results are expressed as the mean 6 S.E.
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Further study of b3 2/2 mice and a2-trans, b3 2/2 mice fed
a high fat diet demonstrated that female mice expressing a2-
ARs had a 2.7-fold increase in total body lipid content and 2.4-
and 3.4-fold increases in perigonadal and inguinal fat pad
weights, respectively (Fig. 4a). Male mice expressing a2-ARs
had a 1.5-fold increase in total body lipid content and 1.5- and
1.7-fold increases in perigonadal and inguinal fat pad weights,
respectively (Fig. 4b). These results demonstrate that in-
creased body weight in high fat diet-fed a2-AR-expressing b3
2/2 mice is due to an expansion of total body fat mass.
To assess the contribution of adipocyte hyperplasia versus
hypertrophy to increased adipose tissue mass, the Hirsch and
Gallian method (19) of lipid extraction and osmium tetroxide
fixation were used to determine fat cell size and number in the
perigonadal depots of high fat diet-fed mice. Fat cell size was
decreased in a2-trans, b3 2/2 mice by 25% in females (not
statistically significant) and by 32% in males. Fat cell number,
on the other hand, was markedly increased in a2-trans, b3 2/2
mice 3.5-fold in females and 1.7-fold in males. These findings
indicate that expansion of adipose tissue mass in 20-week-old
high fat diet-fed a2-trans, b3 2/2 mice is due to adipocyte
hyperplasia and not to an increase in fat cell size. This obser-
vation was confirmed using an alternative method of fat cell
size determination (20, 21) (microscopic assessment of fat cell
size; 600 cells per depot quantified in paraffin-embedded, in-
guinal fat pad sections from female mice) (data not shown).
Obesity is usually associated with elevated blood levels of
glucose, insulin, free fatty acids, and leptin. It has been pro-
posed that these features of obesity are due to the presence of
enlarged adipocytes (28, 29). However, as shown in Fig. 4c,
obese a2-trans, b3 2/2 mice, have normal blood glucose and
insulin levels and reduced fatty acid levels, which is in agree-
ment with hyperplasia without changes in adipocyte size ob-
served in these mice. The weak but significant rise in blood
leptin levels is not associated with increased leptin mRNA
expression in adipose tissue (data not shown) but probably with
the higher number of adipocytes.
DISCUSSION
In the present study we have used genetic engineering in
mice to test the hypothesis that a2/b-AR balance in adipocytes
is an important determinant of total body fat stores. By creat-
ing mice that have a “human-like” pattern of AR expression in
fat (predominance of a2- over b1- and b2-ARs and absence of
b3-ARs), we have demonstrated that increased a2/b-AR bal-
ance promotes high fat diet-induced obesity in mice. Notably,
the development of obesity requires the presence of a2-ARs on
adipocytes, the absence of b3-ARs, and a high fat diet, suggest-
ing an important interaction between two genes (a2 and b3-
AR) and diet on the regulation of total body fat stores.
The present study clearly indicates that increased a2/b-AR
balance in adipocytes promotes high fat diet-induced obesity.
However, the mechanism for this effect has yet to be estab-
lished. Three possibilities are worthy of further discussion.
Firstly, impaired sympathetic activation of lipolysis in white
adipocytes could lead to increased accumulation of triglyceride.
Secondly, impaired sympathetic activation of thermogenesis in
brown adipose tissue could cause decreased energy expenditure
and, consequently, positive energy balance. Thirdly, impaired
sympathetic activation of white adipocytes could cause, via
mechanisms to be discussed below, hyperplasia of white adi-
pose tissue. Detailed analysis of a2-trans, b3 2/2 mice indi-
cates that the first and second possibilities are less likely to be
true. Obesity due to either impaired lipolysis or decreased
energy expenditure would be expected to cause adipocyte en-
largement, a feature common to nearly all models of obesity
(30, 31). In the case of a2-trans, b3 2/2 mice, obesity was due
entirely to adipocyte hyperplasia. In addition, brown fat func-
tion appeared not to be impaired in a2-trans, b3 2/2 mice.
Thus, the fact that enlarged fat mass in a2-trans, b3 2/2 mice
is due entirely to the proliferation of small adipocytes strongly
suggests that high a2/b-AR balance promotes adipocyte
hyperplasia.
The form of obesity observed in high fat diet-fed a2-trans, b3
2/2 mice is atypical because it is due entirely to adipocyte
hyperplasia. In this regard, these animals do not represent
murine models of “typical” human obesity (31). Obesity in hu-
mans as well as rodents is nearly always associated with adi-
pocyte hypertrophy and hyperplasia. Typically, adipocyte hy-
pertrophy occurs early during the development of obesity. It
has been speculated that adipocytes, upon reaching a “critical
FIG. 3. Body weight time course of female (left) and male
(right) mice (n 5 8–11; mean 6 S.E.; *, p < 0.01; unpaired, 2-tailed
t test). a, low fat diet, b3 2/2 background, with or without the a2-AR
transgene (line 1). b, high fat diet, b3 2/2 background, with or without
the a2-AR transgene (line 1). c, high fat diet, b3 2/2 background, with
or without the a2-AR transgene (line 2). d, high fat diet, b3 1/2
background, with or without the a2-AR transgene (line 1).
Human a2-Adrenergic Receptors Promote Diet-induced Obesity34800
 at U
N
IV
 O
F SA
N
 FRA
N
CISCO
 on M
ay 16, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
fat cell size,” release a factor that promotes adipocyte hyper-
plasia; however, the identity of this hypothetical factor is un-
known. The present study indicates that a2-trans, b3 2/2 mice
have a primary disturbance in adipocyte hyperplasia, and on
that basis these animals provide a novel means to explore
pathways controlling adipocyte hyperplasia. One candidate sig-
nal for stimulating adipocyte hyperplasia in a2-trans, b3 2/2
mice is lysophosphatidic acid, a bio-active phospholipid. It has
previously been shown that stimulation of a2-ARs causes re-
lease of lysophosphatidic acid leading to proliferation of pre-
adipocytes (34). Further studies will be required to determine
whether lysophosphatidic acid is the mediator of this effect.
Obese a2-trans, b3 2/2 mice, on the other hand, have an
increased number of small adipocytes, normal blood glucose
and insulin levels, reduced free fatty acid levels, and minimally
elevated leptin levels (Fig. 4c). In this regard, a2-trans, b3 2/2
mice resemble rodents treated with thiazolidinediones (32, 33),
agonists of peroxisome proliferator-activated receptor-g. Based
upon this similarity, it is possible that increased a2/b-AR bal-
ance in adipocytes somehow leads to activation of peroxisome
proliferator-activated receptor-g, possibly through generation
of PPARg ligands.
High fat diet-fed a2-trans, b3 2/2 mice develop an obesity
that is characterized by an increase in both adipocyte number
and lipid storage without any increase in fat cell size. The
findings suggest that, when fed a high fat diet, a2-trans, b3
2/2 mice develop obesity through two mechanisms: (i) an in-
crease in fat cell number due to increased preadipocyte recruit-
ment and (ii) an increase in the ability to store lipids due to
impaired epinephrine-stimulated lipolytic activity. If increased
lipid storage was not present, then average adipocyte size
would have been decreased by an amount reciprocal to the
increase in fat cell number. Because this was not the case, it
must be assumed that lipid storage was also increased, an
effect presumably mediated by a2-AR-induced antilipolytic ac-
tivity, potentiated by the absence of b3-ARs. Thus, the in-
creased fat mass in a2-trans, b3 2/2 mice appears to be due to
both preadipocyte recruitment and increased lipid storage in
the newly recruited adipocytes.
Brown adipocyte function appears not to have been impaired
by transgenic expression of a2-ARs in b3 2/2 mice. This as-
sessment is based upon the observation that cold exposure-
induced changes in UCP1 mRNA in brown fat and body tem-
perature as well as epinephrine-induced effects on whole body
oxygen consumption were not impaired in a2-trans, b3 2/2
mice compared with b3 2/2 control mice. This raises the pos-
sibility that a2-ARs in brown adipocytes were not negatively
coupled to adenylate cyclase. The reason for such failure of
coupling in brown adipocytes, but not white adipocytes, is pres-
ently unknown.
In summary, the present study clearly demonstrates that
increased a2/b-AR balance in adipose tissue promotes diet in-
duced obesity. These findings suggest that increased a2/b-AR
balance, which is frequently observed in human obesity (3–9),
has physiologic significance in the generation of adipocyte hy-
perplasia and the obese state. Identification of the biochemical
mechanism by which a2/b-AR balance and high fat diet pro-
mote adipocyte hyperplasia will focus on the possible roles of
lysophosphatidic acid and peroxisome proliferator-activated re-
ceptor-g. a2-trans, b3 2/2 mice should provide a unique op-
portunity to explore the mechanisms by which expansion of
adipose tissue mass is regulated.
FIG. 4. Assessment of fat stores and
blood parameters in 20-week-old
high fat diet-fed mice. a and b, total
body lipid, fat pad weights, and fat cell
size and number in female (a) and male
(b) mice with (a2-trans, b3 2/2) or with-
out (b3 2/2) the a2-AR transgene (n 5
8–11; mean 6 S.E.; *, p , 0.05; **, p ,
0.01; unpaired, 2-tailed t test). c, blood
parameters (whole blood glucose, serum
free fatty acids (FFAs), insulin, and lep-
tin) in mice with (a2-trans, b3 2/2) or
without (b3 2/2) the a2-AR transgene
(n 5 8–11; mean 6 S.E.; *, p , 0.05; **,
p , 0.01; unpaired, 2-tailed t test).
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